Full Text View
Tabular View
No Study Results Posted
Related Studies
Esomeprazole for Prevention of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDs
This study has been completed.
Study NCT00241514   Information provided by AstraZeneca

First Received on October 18, 2005.   Last Updated on January 20, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
GERD
Additional conditions recognized in this trial
Gastrointestinal Diseases
Signs and Symptoms, Digestive
More general conditions related to this trial
Digestive System Diseases
Signs and Symptoms
Interventions listed in this trial
Esomeprazole
Additional drug interventions recognized in this trial
Anti-Inflammatory Agents, Non-Steroidal
Omeprazole
More general drug interventions related to this trial
Analgesics
Analgesics, Non-Narcotic
Anti-Inflammatory Agents
Anti-Ulcer Agents
Antirheumatic Agents
Enzyme Inhibitors
Gastrointestinal Agents
Molecular Mechanisms of Pharmacological Action
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
AstraZeneca


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services